VORICONAZOLE

Generic: VORICONAZOLE

Xellia Pharmaceuticals USA LLCManufacturer
INTRAVENOUSRoute
VORICONAZOLEActive Substance
2017-03-09Original Approval

VORICONAZOLE is FDA application NDA208562, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
4,031 reports
2
OFF LABEL USE
2,121 reports
3
DRUG INTERACTION
2,063 reports
4
PYREXIA
1,074 reports
5
PNEUMONIA
911 reports
6
BRONCHOPULMONARY ASPERGILLOSIS
897 reports
7
CONDITION AGGRAVATED
879 reports
8
ASPERGILLUS INFECTION
866 reports
9
FEBRILE NEUTROPENIA
756 reports
10
DEATH
727 reports